title: [Methotrexate treatment in Crohn disease].
authors.forename: B
authors.initials: B
authors.lastname: Mesnard
authors.forename: J F
authors.initials: JF
authors.lastname: Colombel
authors.forename: A
authors.initials: A
authors.lastname: Cortot
authors.forename: A
authors.initials: A
authors.lastname: Chiche
authors.forename: C
authors.initials: C
authors.lastname: Gower-Rousseau
authors.forename: J C
authors.initials: JC
authors.lastname: Paris
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000009:adverse effects; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D001379:Azathioprine; D008727:Methotrexate
vernacular_title: Traitement de la maladie de Crohn par méthotrexate.